CYP26B1 and neoplasm: CYP26B1 negative/weak/moderate expressing tumours when compared with CYP26B1 strongly expressing tumours also showed a highly significant association with survival (HR = 1.737, 95%CI = 1.248–2.418, χ2 = 11.092, p = 0.001).